Na-131I (solution for injection)

MI-2

Indications

The medicinal product is used:

  • in the diagnosis of thyroid function disorders (hyperthyroidism and hypothyroidism), evaluation of thyroid tissue location (including ectopy), its size, shape, functional analysis of focal lesions: “cold” (not trapping iodine), “warm” (trapping iodine at a similar extent to normal thyroid parenchyma), “hot” (trapping iodine at a higher extent than the normal thyroid parenchyma) nodules.
  • to study radioiodine location in thyroid tissue
  • an estimation of the thyroid uptake and the iodine effective half-life can be used to calculate the dose of radioiodine planned for therapy.
  • in the management of patients with differentiated thyroid carcinoma in order to identify the remaining thyroid tissue after surgery and in the diagnostics of metastases.
  • in the treatment of benign thyroid diseases: thyroid nodular goitre, hyperthyroidism in the Graves-Basedow’s disease, autonomic nodule, the toxic multinodular goiter, differentiated thyroid cancer, for the thyroid residue ablation after surgery and in the treatment of iodine-accumulating metastases.

Shelf life
28 days from the production date

Shelf-life and storage conditions after radiolabelling

  • at temperature below 25ºC
Please note that this product does not have a Marketing Authorization (MA) in NL/BE/LUX.